tiprankstipranks
Trending News
More News >

Viridian Therapeutics announces inducement grant under Nasdaq listing rule

Viridian Therapeutics (VRDN) announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qualified stock options to purchase an aggregate of 175,000 shares of the company’s common stock to one new employee on July 1, 2025. The Inducement Grant has been granted outside of the company’s Amended and Restated 2016 Equity Incentive Plan but remains subject to the terms and conditions of such Plan. The Inducement Grant was granted as an inducement material to the individual entering into employment with Viridian in accordance with Nasdaq Listing Rule 5635(c)(4).

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1